These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28875522)

  • 1. Developments in the synthesis of the antiplatelet and antithrombotic drug (S)-clopidogrel.
    Saeed A; Shahzad D; Faisal M; Larik FA; El-Seedi HR; Channar PA
    Chirality; 2017 Nov; 29(11):684-707. PubMed ID: 28875522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis by thienopyridines and their congeners.
    Gryglewski RJ; Dupin JP; Uracz W; Swiês J; Madej J; Hou G; Gravier D; Casadebaig F
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):683-93. PubMed ID: 11192941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming clopidogrel resistance: discovery of vicagrel as a highly potent and orally bioavailable antiplatelet agent.
    Shan J; Zhang B; Zhu Y; Jiao B; Zheng W; Qi X; Gong Y; Yuan F; Lv F; Sun H
    J Med Chem; 2012 Apr; 55(7):3342-52. PubMed ID: 22428882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive antithrombotic effect of ASP6537, a selective cyclooxygenase (COX)-1 inhibitor, in combination with clopidogrel in guinea pigs.
    Sakata C; Suzuki KI; Morita Y; Kawasaki T
    Eur J Pharmacol; 2017 Mar; 798():72-76. PubMed ID: 28095326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-chlorophenyl zinc bromide: a convenient nucleophile for the mannich-related multicomponent synthesis of clopidogrel and ticlopidine.
    Aillaud I; Haurena C; Gall EL; Martens T; Ricci G
    Molecules; 2010 Nov; 15(11):8144-55. PubMed ID: 21072025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel: a new antiplatelet drug.
    Lerner RG; Frishman WH; Mohan KT
    Heart Dis; 2000; 2(2):168-73. PubMed ID: 11728254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the enantiomers of ZJM-289: synthesis and biological evaluation of antiplatelet, antithrombotic and neuroprotective activities.
    Wang X; Zhao Q; Wang X; Li T; Lai Y; Peng S; Ji H; Xu J; Zhang Y
    Org Biomol Chem; 2012 Dec; 10(45):9030-40. PubMed ID: 23076046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor.
    Vilahur G; Pena E; Padró T; Badimon L
    Thromb Haemost; 2007 Apr; 97(4):650-7. PubMed ID: 17393029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and stereochemistry of the active metabolite of clopidogrel.
    Pereillo JM; Maftouh M; Andrieu A; Uzabiaga MF; Fedeli O; Savi P; Pascal M; Herbert JM; Maffrand JP; Picard C
    Drug Metab Dispos; 2002 Nov; 30(11):1288-95. PubMed ID: 12386137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel.
    Nishiya Y; Hagihara K; Kurihara A; Okudaira N; Farid NA; Okazaki O; Ikeda T
    Xenobiotica; 2009 Nov; 39(11):836-43. PubMed ID: 19845434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model.
    Wåhlander K; Eriksson-Lepkowska M; Nyström P; Eriksson UG; Sarich TC; Badimon JJ; Kalies I; Elg M; Bylock A
    Thromb Haemost; 2006 Mar; 95(3):447-53. PubMed ID: 16525572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the antiplatelet effect of two clopidogrel bisulfate formulations: Plavix and generic-Egitromb.
    Komosa A; Siller-Matula JM; Kowal J; Lesiak M; Siniawski A; Mączyński M; Michalak M; Mularek-Kubzdela T; Grajek S
    Platelets; 2015; 26(1):43-7. PubMed ID: 24499166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of Biologically Active Piperidine Metabolites of Clopidogrel: Determination of Structure and Analyte Development.
    Shaw SA; Balasubramanian B; Bonacorsi S; Cortes JC; Cao K; Chen BC; Dai J; Decicco C; Goswami A; Guo Z; Hanson R; Humphreys WG; Lam PY; Li W; Mathur A; Maxwell BD; Michaudel Q; Peng L; Pudzianowski A; Qiu F; Su S; Sun D; Tymiak AA; Vokits BP; Wang B; Wexler R; Wu DR; Zhang Y; Zhao R; Baran PS
    J Org Chem; 2015 Jul; 80(14):7019-32. PubMed ID: 26151079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of SanOrg123781A, a synthetic hexadecasaccharide, in a mouse model of electrically induced carotid artery injury: synergism with the antiplatelet agent clopidogrel.
    Lorrain J; Lechaire I; Gauffeny C; Masson R; Roome N; Herault JP; O'Connor SE; Schaeffer P; Herbert JM
    J Pharmacol Exp Ther; 2004 Apr; 309(1):235-40. PubMed ID: 14718579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Liver Cytochrome P450 Enzymes and Microsomal Thiol Methyltransferase Are Involved in the Stereoselective Formation and Methylation of the Pharmacologically Active Metabolite of Clopidogrel.
    Liu C; Chen Z; Zhong K; Li L; Zhu W; Chen X; Zhong D
    Drug Metab Dispos; 2015 Oct; 43(10):1632-41. PubMed ID: 26220948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of nitric oxide releasing derivatives of 3-n-butylphthalide as antiplatelet and antithrombotic agents.
    Wang X; Li Y; Zhao Q; Min Z; Zhang C; Lai Y; Ji H; Peng S; Zhang Y
    Org Biomol Chem; 2011 Aug; 9(16):5670-81. PubMed ID: 21706121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of hydrogen sulfide releasing derivatives of 3-n-butylphthalide as potential antiplatelet and antithrombotic agents.
    Wang X; Wang L; Sheng X; Huang Z; Li T; Zhang M; Xu J; Ji H; Yin J; Zhang Y
    Org Biomol Chem; 2014 Aug; 12(31):5995-6004. PubMed ID: 24988475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified asymmetric Strecker reaction of aldehyde with secondary amine: a protocol for the synthesis of S-clopidogrel (an antiplatelet agent).
    Sadhukhan A; Saravanan S; Khan NU; Kureshy RI; Abdi SH; Bajaj HC
    J Org Chem; 2012 Aug; 77(16):7076-80. PubMed ID: 22834772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a novel class of antithrombotic compounds with dual function. Discovery of 1,4-benzoxazin-3(4H)-one derivatives possessing thrombin inhibitory and fibrinogen receptor antagonistic activities.
    Stefanic Anderluh P; Anderluh M; Ilas J; Mravljak J; Sollner Dolenc M; Stegnar M; Kikelj D
    J Med Chem; 2005 May; 48(9):3110-3. PubMed ID: 15857114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Nitrosoimino-3,6-dihydro-2H-1,3,4-thiadiazines with antiplatelet and antithrombotic properties.
    Rehse K; Brümmer U; Unsöld E
    Pharmazie; 1998 Dec; 53(12):820-4. PubMed ID: 9879566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.